Furthermore, our in vivo evidence also demonstrated that Sirt7 knockdown was not sufficient to reduce gastric cancer cell growth when miR-34a was stably knocked down (Fig. 6E and Suppl. This evidence concerns the gene SIRT7 and gastric cancer.